AbbVie's head of global head of immunology discovery research says the ability to profile patients at the molecular level has the potential to dramatically change treatment for people living with chronic conditions. …
New testing means patients no longer 'defined by their symptoms'
February 26, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
The 'zombie' reform that is still meant to happen
November 22, 2019 - - Latest News -
Novo Nordisk partners with UN on childhood obesity
November 22, 2019 - - Latest News -
60-day dispensing would mean hundreds of new listings
November 22, 2019 - - Latest News -
Sustainability recognition for Amgen at national awards
November 22, 2019 - - Latest News -
NPSA: Commitment to 'Australia’s critical infrastructure for health'
November 21, 2019 - - Latest News -
Wholesaler move to go it alone is just one key difference
November 21, 2019 - - Latest News -
Greg Hunt frustrated over refusal to treat with CAR-T
November 21, 2019 - - Latest News